scutellarin has been researched along with Amyloid Deposits in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
An, H; Dou, F; Huang, Y; Lai, Y; Liu, W; Peng, D; Shao, W; Wang, L; Wei, D; Yang, T; Zhang, J; Zhang, S; Zhang, Z | 1 |
1 other study(ies) available for scutellarin and Amyloid Deposits
Article | Year |
---|---|
Dengzhan Shengmai capsules and their active component scutellarin prevent cognitive decline in APP/PS1 mice by accelerating Aβ aggregation and reducing oligomers formation.
Topics: Amyloid beta-Peptides; Animals; Apigenin; Cognitive Dysfunction; Drugs, Chinese Herbal; Glucuronates; Humans; Hydrophobic and Hydrophilic Interactions; Male; Mice, Inbred C57BL; Mice, Transgenic; Molecular Weight; Plaque, Amyloid; Presenilin-1; Protein Aggregates; Protein Multimerization; Solubility | 2020 |